PDCD1 and neoplasm: These agents block proteins and ligands, such as cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) and programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1), that ordinarily inactivate cytotoxic T cells, which are important players of the immune system against tumor cells.